Key facts
- It has raised $1.4M; the latest was Seed Round ($1.4M) in Apr 2025.
- Notable investors include Z&Y Capital, Xihu VC.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Meiyin Intelligent
- ·The full record, as it builds
Funding rounds
No funding rounds for Meiyin Intelligent are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Meiyin Intelligent
Developer of a platform and AI agent for major disease risk prediction and disease risk management. The company focuses on using artificial intelligence technology to empower disease risk prediction and health management, providing AI-driven insurance and disease risk management solutions for people at risk of serious and chronic diseases.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Meiyin Intelligent doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Meiyin Intelligent shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Meiyin Intelligent in its N-PORT filings yet. We sweep new filings monthly.